Systemic scleroderma and small cell carcinoma of the lung
β Scribed by Deba P. Sarma; Thomas G. Weilbaecher
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 266 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A 64βyearβold man diagnosed to have systemic scleroderma for 1 year developed smallβcell carcinoma of the lung. Six additional cases obtained from the literature describing smallβcell carcinoma occurring in patients with scleroderma are reviewed.
π SIMILAR VOLUMES
## BACKGROUND. The number of elderly people with small cell lung carcinoma (SCLC) is increasing and currently nearly 25% are older than 70 years. Elderly patients may not tolerate intensive therapy and, therefore, often do not receive such treatment. Additionally, age may be an independent predicto
## Abstract Small cell carcinoma of the lung is extremely sensitive to chemotherapy and radiation therapy. We describe the case of a patient who had a complete response to such treatment but relapsed with meningeal carcinomatosis. We propose that prophylactic therapy to the spinal cord as well as t
Twenty previously untreated patients with small cell carcinoma of the lung were treated with cyclophosphamide, 400 mg/m2 and Adriamycin, 40 mg/m2 IV on day 1, followed by cytosine arabinoside, 20 mg/m2, every 12 hours subcutaneously on days 5--9; this regimen was repeated every 28 days. On days 14--